Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Immunotherapy Plus TKI Regimens Appear Promising for Patients With Renal Cell Carcinoma

Targeted Oncology - In an interview with Targeted Oncology, Chung-Han (Joe) Lee, MD, PhD, discussed the use of different targeted therapy and immunotherapy strategies for the treatment of patients with metastatic kidney cancer.

Read the full article here

Related Content